MedTrace Logo

Aromatherapy Inhaler Use for HSCT Distress

NCT05302583 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-04-13

No results posted yet for this study

Summary

The purpose of this research is to evaluate aromatherapy inhaler use and how it may impact cancer distress and coping by patients in the first few days after hematopoietic stem cell transplant (HSCT).

Conditions

  • Cancer Distress
  • Cancer Coping
  • Hematopoetic Stem Cell Transplant
  • Aromatherapy

Interventions

OTHER

Aromatherapy Inhaler

Lavender Aromatherapy Inhaler Peppermint Aromatherapy Inhaler

Sponsors & Collaborators

Principal Investigators

  • Anna Oh, PhD, MPH, RN · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-16
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05302583 on ClinicalTrials.gov